Healthcare -
Biotechnology - NASDAQ - US
$ 11.21
-3.36 %
$ 682 M
Market Cap
-3.35
P/E
PLRX - TOTAL EQUITY
Total Equity PLRX - Pliant Therapeutics, Inc.
474 M
LAST VALUE
54.24%
2 YEAR CAGR
251.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR